ASTHMA TREATMENT is a specialized pharmaceutical solution designed for effective management and relief of asthma symptoms. It typically encompasses a range of medications such as inhalers, bronchodilators, corticosteroids, and other anti-inflammatory drugs tailored to control airway inflammation, prevent asthma attacks, and ease breathing difficulties. This treatment is intended for medical professionals and healthcare providers focusing on respiratory care, offering different formulations for acute and long-term asthma management. The product ensures improved patient compliance with easy-to-use delivery systems and clinically approved ingredients that conform to medical standards for asthma care in India.
Key Features
| Features | Description |
|---|---|
| Type of Medication | Inhalers, Bronchodilators, Corticosteroids |
| Purpose | Management and relief of asthma symptoms |
| Usage | Acute and long-term asthma control |
| Delivery System | Metered dose inhalers, Dry powder inhalers |
| Formulation | Sterile, clinically tested pharmaceutical compounds |
| Indications | Prevention of asthma attacks, reduction of airway inflammation |
| Packaging | Leak-proof, portable inhaler devices or medicinal vials |
| Regulatory Compliance | CDSCO approved and compliant with Indian pharma standards |
| Attributes | Description |
|---|---|
| Active Ingredients | Salbutamol, Budesonide, Fluticasone, Formoterol (varies by formulation) |
| Dosage Form | Inhaler / Nebulizer solution |
| Indicated Age Group | Children (above 6 years) and adults |
| Shelf Life | 24 months from date of manufacture |
| Storage Conditions | Store below 30°C, protect from moisture and direct sunlight |
| Manufacturer Certification | GMP certified production facility |
| Country of Origin | India |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
This asthma treatment specifically targets symptoms like airway inflammation, bronchoconstriction, wheezing, coughing, and shortness of breath through the use of bronchodilators and corticosteroids.
Yes, the range includes formulations designed for immediate relief during acute asthma episodes as well as long-term control medications to reduce airway inflammation and prevent future attacks.
The products come primarily in metered dose inhalers and dry powder inhalers, ensuring precise dosage and convenience for patient use.
All components and formulations within the asthma treatment product range are approved by CDSCO and manufactured in GMP-certified facilities to meet Indian pharmaceutical standards.
These medications should be stored below 30°C, away from moisture and direct sunlight, and have a typical shelf life of 24 months from the date of manufacture.
Country Of Origin: India
